Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study

Blood

Volumn 88, Issue 10, 1996, Pages 4063-4071

  Boeckh, Michael ^a,b   Gooley, Ted A ^a   Myerson, David ^a   Cunningham, Terri ^a   Schoch, Gary ^a   Bowden, Raleigh A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN; METHOTREXATE; VIRUS ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOMA; MALE; MYCOSIS; MYELOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; VIRUS DETECTION; VIRUS INFECTION;

EID: 0029800728     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.4063.bloodjournal88104063     Document Type: Article

References (40)

1. Goodrich JM, Mon M, Gleaves CA, DuMond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD: Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325:1601, 1991
2. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA: A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324:1005, 1991
3. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD: Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173, 1993
4. Einsele H, Ehninger G, Hebart H, Wittkowski KM, Schuler U, Jahn G, Mackes P, Hertes M, Klingebiel T, Löffler J, Wagner S, Müller CA: Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815, 1995
5. Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles W, Champlin RE: Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Ann Intern Med 118:179, 1993
6. Li C-R, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR: Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971, 1994
7. van der Bij W, Torensma R, van Son WJ, Anema J, Schirm J, Tegzess AM, The TH: Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 25:179, 1988
8. Einsele H, Steidle M, Vallbracht A, Saal JG, Ehninger G, Müller CA: Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104, 1991
9. Wolf DG, Spector SA: Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 56:330, 1993
10. Aspin MM, Gallez-Hawkins GM, Giugni TD, Tegtmeier B, Lang DJ, Schmidt GM, Forman SJ, Zaia JA: Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 32:2266, 1994
11. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD: Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358, 1992
12. Boeckh M, Myerson D, Bowden RA: Early detection and treatment of cytomegalovirus infections in marrow transplant - Methodological aspects and implications for therapeutic interven-tions. Bone Marrow Transplant 14:S66, 1994
13. Vlieger AM, Boland GJ, Jiwa MM, de Weger RA, Willemze R, de Gast GC, Falkenburg JHF: Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant 9:247, 1992
14. Buckner CD, Clift RA, Appelbaum FR, Storb R, Petersen FB, Sanders JE, Thomas ED, Hansen JA: Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone Marrow Transplant 7:6, 1991
15. Storb R, Leisenring W, Deeg HJ, Anasetti C, Appelbaum F, Bensinger W, Buckner CD, Clift R, Doney K, Hansen J, Martin P, Sanders J, Stewart P, Sullivan K, Thomas ED, Witherspoon R: Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia (letter). Blood 83:2749, 1994
16. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA: Efficacy and safety of fluconazole for fungal infections after marrow transplant - A prospective, randomized, double-blind study. J Infect Dis 171:1545, 1995
17. Boeckh M, Woogerd PM, Stevens-Ayers T, Ray CG, Bowden RA: Factors influencing detection of quantitative cytomegalovirus antigenemia. J Clin Microbiol 32:832, 1994
18. Gleaves CA, Smith TF, Shuster EA, Pearson GR: Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 21:217, 1985
19. Boeckh M, Cleaves CA, Bindra R, Meyers JD: Comparison of MRC-5 and U-373MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures. Eur J Clin Microbiol Infect Dis 10:569, 1991
20. Gerna G, Revello MG, Percivalle E, Morini F: Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30:1232, 1992
21. Finckh U, Lingenfelter PA, Myerson D: Producing single stranded DNA probes with the Taq DNA polymerase: A high yield protocol. Biotechniques 10:35, 1991
22. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472, 1991
23. Myerson D, Lingenfelter PA, Gleaves CA, Meyers JD, Bowden RA: Diagnosis of cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid. Am J Clin Pathol 100:407, 1993
24. Makuch R: Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep 62:1037, 1978
25. The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes - A review of the antigenemia assay and polymerase chain reaction. Transplantation 54:193, 1992
26. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M, Battaglia M: Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 28:2681, 1990
27. van der Berg AP, van der Bij W, van der Son WJ, Anema J, van der Giessen M, Schirm J, Tegzess AM, The TH: Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - A report of 130 consecutive cases. Transplantation 48:991, 1989
28. van den Berg AP, Klompmaker IJ, Haagsma EB, Scholten-Sampson A, Bijleveld CMA, Schirm J, van der Giessen M, Slooff MJH, The TH: Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis 164:265, 1991
29. Gerna G, Zipeto D, Parea M, Grazia Revello M, Silini E, Percivalle E, Zavattoni M, Grossi P, Milanesi G: Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart ansplant patients by determination of viremia, antigenemia, and DNAemia. J Infect Dis 164:488, 1991
30. Bowden RA, Digel J, Reed EC, Meyers JD: Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J Infect Dis 156:899, 1987
31. Heagy W, Crumpacker C, Lopez PA, Finberg RW: Inhibition of immune functions by antiviral drugs. J Clin Invest 87:1916, 1991
32. Quinnan GV, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH: Cytotoxic T cells in cytomegalovirus infection. N Engl J Med 307:7, 1982
33. Reusser P, Riddell SR, Meyers JD, Greenberg PD: Cytotoxic T-lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373. 1991
34. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238, 1992
35. Gonczol E, Ianacone J, Ho W, Starr S, Meignier B, Plotkin S: Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers. Vaccine 8:130, 1990
36. McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR: Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific CTL. J Med Virol 43:103, 1994
37. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
38. Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP, Budinger MD, Schwartz RS, Appelbaum FR, Clift RA, Hansen JA, Sanders JE, Thomas ED, Storb R: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705, 1990
39. Sayer HG, Longton G, Bowden R, Pepe M, Storb R: Increased risk of infection in marrow transplant patients given methylprednisolone for graft-versus-host disease prevention. Blood 84:1328, 1994
40. Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA: Phase I study of amphotercin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 173:1208, 1996